THE SHORT ANSWER
Does Kaiser Cover Wegovy?
Coverage Is Extremely Limited
Most Kaiser standard HMO (Health Maintenance Organization) plans do NOT cover Wegovy for weight loss. As of January 1, 2025, Kaiser California removed GLP-1 (a class of weight loss medications) coverage from base plans for members with BMI (body mass index) under 40.[1]
Kaiser Permanente operates differently than traditional insurers. Because your doctor works for your insurance company, getting an "off-formulary" (not on your plan's approved drug list) medication like Wegovy is harder than with other insurers.
| Situation | Coverage? | Details |
|---|---|---|
| Weight loss (BMI < 40) | Usually No | Removed from base coverage 1/1/2025 in California |
| Weight loss (BMI ≥ 40) | Limited | May be covered with strict step therapy requirements |
| Type 2 Diabetes | Varies | May cover Mounjaro (same drug) if other meds fail |
| Sleep Apnea (OSA) | No Wegovy indication | Wegovy has no FDA approval for sleep apnea; Zepbound is the GLP-1 approved for OSA |
Bottom line: Kaiser is one of the hardest insurers for Wegovy coverage. If you're a Kaiser member wanting Wegovy for weight loss, prepare for significant hurdles—or consider alternatives like NovoCare self-pay.
Realistic Path for Most Kaiser Members
If you don't have employer opt-in coverage or BMI ≥40, NovoCare Pharmacy may be your most practical path: injectable at $199–$349/month, or the new oral pill at $149–$299/month.[4] No prior authorization, no step therapy, home delivery included.
California Member? You Have Options
The California DMHC (Department of Managed Health Care) Independent Medical Review overturns ~60% of medical necessity denials. If Kaiser denies you, this is your most powerful tool. Learn about CA DMHC IMR →
How to Check Your Specific Coverage
Call Script for Kaiser
"Hi, I'm calling to check coverage for a prescription medication. My member ID is [NUMBER]. I need to know:
- Is Wegovy (semaglutide) covered on my plan's formulary for weight management?
- If not, is it covered for cardiovascular risk reduction?
- What are the coverage criteria—BMI, step therapy, lifestyle documentation?
- Does my employer's plan include GLP-1 weight loss drug coverage?
- Can you send me the formulary exception request process in writing?"
Kaiser Member Services by Region:
- Northern California: 1-800-464-4000
- Southern California: 1-833-574-2273 (24/7)
- Other regions: Check your member ID card
Script for Asking HR About Coverage
"Hi, I have a question about our Kaiser benefits. Does our company's plan include coverage for GLP-1 weight loss medications like Wegovy or Wegovy? I understand Kaiser removed these from base coverage in 2025, but some employers opted to add this benefit. Can you check our plan documents or contact our Kaiser rep?"
Email Template for HR (Copy & Paste)
Subject: Question About GLP-1 Weight Loss Drug Coverage
Hi [HR Contact],
I'm researching my Kaiser benefits and have a question. I understand Kaiser removed GLP-1 weight loss medications (like Wegovy/Wegovy) from base coverage in 2025, but some employers opted to add this benefit.
Could you check if our company's Kaiser plan includes weight loss drug coverage? If not, is this something that could be considered for next year's benefits review?
Thank you,[Your Name]
THE INSURER-PROVIDER LOOP
Why Kaiser Is Different
Understanding why Kaiser coverage works differently than other insurers is critical to navigating your options:
Your Doctor Works for Your Insurance
Unlike other insurers where your doctor is independent, Kaiser doctors are Kaiser employees. They follow strict internal protocols and typically cannot (or won't) prescribe medications outside the Kaiser formulary.
What This Means for You
- No "fighting" with insurance separately — Your doctor and insurer are the same organization
- Internal formulary is law — Kaiser doctors prescribe from the Kaiser drug list
- Less prescriber flexibility — Independent doctors can advocate more aggressively; Kaiser doctors follow company protocols
- Exception requests go through the same system — You're asking Kaiser to override Kaiser's own decision
This doesn't mean coverage is impossible—but it requires understanding Kaiser's specific processes, including their "grievance" system (not just "appeal") and knowing when to escalate to the California DMHC.
KAISER FORMULARY BY REGION
2025 Regional Coverage Status
Kaiser operates as separate regional entities, each with its own formulary. Coverage varies significantly:
Check Your Regional Formulary
Look up Wegovy on Kaiser's official formulary tools:
| Region | Weight Loss Coverage? | Key Details |
|---|---|---|
| California (NCAL/SCAL) | Removed 1/1/2025 | GLP-1s excluded from base coverage for BMI < 40; employer opt-in only[1] |
| Northwest (OR/WA) | Limited | Requires failed trial of 2 other meds + 6 months semaglutide[3] |
| Colorado | Varies | Check specific plan; often requires metabolic program enrollment |
| Mid-Atlantic (DC/MD/VA) | Varies | "Select" vs "Standard" plans differ; check your specific plan |
| Georgia | Varies | Limited coverage; employer-specific benefits |
| Hawaii | Varies | Check specific plan formulary |
| FEHB (Federal Employees) | Limited | May cover with PA; $45-65/month copay if approved[2] |
California Alert: 2025 Coverage Changes
Effective January 1, 2025, Kaiser California implemented major restrictions for GLP-1 weight loss drugs. Coverage is now removed from base commercial and Individual & Family plans when prescribed solely for weight loss in patients with BMI < 40.[1]
GLP-1s remain covered for:
- BMI ≥ 40 (Class III/morbid obesity)
- Type 2 Diabetes (Mounjaro, not Wegovy)
- Major Adverse Cardiac Events history
- Employers who opt-in to add weight loss drug coverage
WHAT KAISER REQUIRES FIRST
Kaiser Wegovy Step Therapy Requirements
Even in regions where Kaiser covers Wegovy, you must typically "fail" multiple other treatments first:
Kaiser Northwest Example (Most Documented)
To qualify for Wegovy coverage in Kaiser Northwest, you must demonstrate:[3]
Kaiser Wegovy Coverage Criteria
- BMI ≥ 30 (obesity) OR BMI ≥ 27 with a comorbidity (a related health condition like hypertension, diabetes, or high cholesterol)
- Age 18+
- Following a structured diet and exercise program (documented, not just attested)
- Failed at least 2 prior weight loss medications[8]:
- Phentermine
- Diethylpropion
- Qsymia (phentermine/topiramate)
- Contrave (naltrexone/bupropion)
- Tried semaglutide (Wegovy or Ozempic) for minimum 6 months and either:
- It was ineffective (didn't achieve target weight loss)
- Cannot tolerate due to allergy, serious side effects, or contraindication
Continuation Requirements (To Keep Coverage)
- Initial approval typically for 12 months
- Must document at least 5% weight loss after starting semaglutide to continue coverage
- Bariatric medicine chart review required before switching from semaglutide to Wegovy
Kaiser's Internal "Medical Weight Management" Program
Kaiser often requires patients to enroll in their internal weight management program before approving GLP-1s. This may include:
- Structured diet plans (sometimes liquid/shake-based)
- Regular check-ins with Kaiser dietitians
- Documented participation for a set period
Ask your Kaiser PCP (primary care provider) about this program—completing it may strengthen a formulary exception request.
Medical Necessity Checklist for Formulary Exception
If you're requesting a formulary exception, gather this documentation first:
Required Documentation for Exception Request
- Current BMI documentation (≥30 or ≥27 with comorbidity)
- Documented comorbidities with ICD-10 codes (medical diagnosis codes):
- Obesity Class I/II/III (E66.811, E66.812, E66.813)
- Hypertension (I10)
- Type 2 Diabetes (E11)
- Dyslipidemia/high cholesterol (E78.5)
- Obstructive Sleep Apnea (G47.33)
- Failed alternative treatments — documented trials of:
- Phentermine or diethylpropion
- Qsymia or Contrave
- Semaglutide (Wegovy/Ozempic) for 6+ months
- Lifestyle modification records (diet/exercise program participation)
- Weight history showing chronic obesity (past 1-2 years)
- Letter of Medical Necessity from your Kaiser provider
For more on prior auth documentation, see our Wegovy prior authorization guide →
EXCEPTION PATHWAYS
How Some Members Get Coverage
While standard coverage is limited, some Kaiser members do get Wegovy covered. Here's how:
Employer Opt-In Plans
Some employers specifically add GLP-1 weight loss drug coverage to their Kaiser plan. Check with your HR department—you may have coverage even if standard Kaiser plans don't include it.
Medical Necessity Exception
Request a formulary exception for medical necessity. This requires:
- Documentation of failed alternative treatments
- Clear medical rationale why Wegovy specifically is needed
- Supporting evidence from your Kaiser provider
Weight-loss requests face Kaiser’s strict criteria; requests for other FDA-approved uses follow different criteria.
Sleep Apnea (OSA): Ask About Zepbound
Important: Wegovy Is NOT FDA-Approved for OSA
On December 20, 2024, the FDA approved Zepbound (tirzepatide)—not Wegovy—as the first medication for moderate-to-severe obstructive sleep apnea (OSA) in adults with obesity.[14] Wegovy has no FDA-approved sleep apnea indication, so an OSA coverage pathway doesn’t apply to Wegovy.
If you suspect you have OSA (snoring, daytime fatigue, witnessed breathing pauses), ask your Kaiser PCP for a sleep study referral and whether Zepbound is appropriate for you.
Dual Coverage / Out-of-Network
If you have secondary insurance through a spouse or other source, the secondary insurer may cover what Kaiser doesn't. Some Kaiser plans also have out-of-network pharmacy benefits—check your Evidence of Coverage document.
Your GLP-1 coverage,
denied approved
If Kaiser denies your Wegovy, Honest Care can help you build a strong appeal with evidence-backed documentation.
Denied by Kaiser?
Get Help NowYOUR OPTIONS
If Your Kaiser Doctor Won't Prescribe
Because Kaiser doctors follow internal protocols, you may hit a wall before even getting to the coverage question. If your PCP won't prescribe Wegovy:
Option 1: Request a Referral to Bariatric Medicine
Kaiser's internal bariatric medicine or endocrinology specialists may have more flexibility. Ask for a referral and explain your interest in GLP-1 medications.
Option 2: Telehealth + Self-Pay
If Kaiser won't prescribe, you can get a prescription from an outside telehealth provider. Important caveat: External prescriptions typically aren't covered by Kaiser pharmacy—you'll pay out of pocket.
| Scenario | Cost | Details |
|---|---|---|
| With Kaiser coverage (if approved) | $25-65/month | Copay varies by plan; rare to get approved[2] |
| NovoCare Pharmacy (injectable) | $199–$349/month | $199/month for the first two fills (0.25 mg and 0.5 mg), through December 31, 2026; standard doses $349/month ($399 for Wegovy HD 7.2 mg)[4] |
| Oral Wegovy pill (new Jan 2026) | $149–$299/month by dose | $149 (1.5 mg), $199 (4 mg), $299 (9 mg and 25 mg) via NovoCare[15] |
| Wegovy Savings Card | as little as $25 | Only works with commercial insurance that covers Wegovy (not Kaiser typically) |
| Retail pharmacy (no coverage) | ~$1,600/month | Average retail ~$1,615[12]; GoodRx coupons may reduce cost |
For complete self-pay options including NovoCare pricing, see our Wegovy cost guide →
Option 3: Switch Plans During Open Enrollment
If GLP-1 coverage is important to you and Kaiser won't provide it, consider switching to a different insurer during open enrollment. Check our Is Wegovy Covered by Insurance? to compare options.
KAISER'S SPECIFIC PROCESS
Grievance vs. Appeal
Kaiser Uses Different Terminology
Kaiser calls many issues "grievances" rather than "appeals." If you can't get a prescription or referral, you file a grievance. If you're denied coverage for a specific drug, that may be a coverage redetermination or appeal.
When to File What
| Situation | Kaiser Term | What to Do |
|---|---|---|
| Doctor won't prescribe Wegovy | Grievance | File grievance about access to care/treatment |
| Can't get referral to specialist | Grievance | File grievance about denied referral |
| Prescription denied by pharmacy | Coverage Appeal | Request formulary exception or redetermination |
| Prior auth denied | Appeal | File appeal by the deadline in your denial letter (ACA plans must allow at least 180 days)[5] |
Your GLP-1 coverage,
denied approved
Not sure which to file? Honest Care can review your denial and help you build a strong, evidence-backed appeal—whether it's a grievance or coverage appeal.
Need Guidance?
Get Help NowHow to File a Kaiser Grievance/Appeal
Contact Information
- Phone (expedited appeals): 1-866-206-2973
- Online: kp.org member portal
- In writing: Check your denial letter for the specific address for your region
Deadline: the deadline in your denial letter (ACA plans must allow at least 180 days)[5]
What to Include
- Your member ID and contact information
- Copy of the denial letter
- Letter explaining why you need Wegovy specifically
- Documentation of failed alternatives
- Supporting clinical evidence (STEP trial data[9])
- Letter from your prescriber supporting the request
Kaiser must respond to standard appeals within 30 days. For urgent situations where waiting could harm your health, you can request an expedited review with a decision within 72 hours.[5]
For general appeal strategies that work across all insurers, see our Wegovy appeals guide →
THE NUCLEAR OPTION FOR CA MEMBERS
California DMHC IMR for Wegovy Denials
California Members Have Powerful Options
The California Department of Managed Health Care (DMHC) oversees Kaiser in California. If Kaiser denies your appeal, you can request an Independent Medical Review (IMR)—and the results are striking.
IMR Success Rates
According to DMHC data, Independent Medical Reviews frequently overturn insurance denials:[6]
| Denial Type | Overturned | Upheld | Reversed by Plan |
|---|---|---|---|
| Medical Necessity (Blue Shield 2023) | 55.3%[7] | 19.2% | 25.5% |
| All Types Combined | ~60%+ | ~20% | ~20% |
Key insight: Roughly 80% of medical necessity denials are either overturned by the DMHC or reversed by the insurance plan before the IMR is completed. Senator Scott Wiener cites 72% of denials reaching IMR are overturned.[13] Plans often reconsider when they know an IMR is coming.[6]
How to File for IMR
Exhaust Kaiser's Internal Process First
You typically must complete Kaiser's grievance/appeal process before requesting IMR. Exception: If your health would be seriously harmed by waiting, you can file for IMR immediately.
Contact the DMHC
Visit dmhc.ca.gov[10] or call 1-888-466-2219 (TDD: 1-877-688-9891). You can file online, by phone, or by mail.
Submit Your Request
Include all documentation: denial letters, your appeal, medical records, and any supporting evidence.
Wait for Decision
Standard: Decision within 30 days. Expedited: 72 hours if imminent and serious threat to health.
IMR Decisions Are Binding
Unlike Kaiser's internal appeals, an IMR decision is legally binding on Kaiser. If the IMR rules in your favor, Kaiser must provide coverage. This is why IMR is often called the "nuclear option"—it's your most powerful tool as a California member.
Your GLP-1 coverage,
denied approved
Before filing with DMHC, you need a strong appeal with solid documentation. Honest Care helps you build evidence-backed appeals that give you the best chance of success.
Denied by Kaiser?
Build Your AppealWHAT'S CHANGING
Kaiser Coverage Outlook for 2026
Kaiser's strict GLP-1 weight loss restrictions are expected to continue through 2026. California DMHC Independent Medical Review remains your most powerful tool if denied (~55% of medical necessity denials overturned). Kaiser Medicare Advantage members: see our Medicare guide for 2026 policy updates.
Self-pay outlook: TrumpRx.gov launched on February 5, 2026. TrumpRx lists the manufacturers’ own self-pay prices (not a separate, cheaper price), so for Wegovy it shows the same self-pay price as NovoCare ($349/month ($399 for Wegovy HD 7.2 mg)).[11]
COMMON QUESTIONS
Kaiser Wegovy FAQs
Usually no, especially after January 2025. Kaiser California removed GLP-1 weight loss drugs from base coverage for members with BMI under 40 effective 1/1/2025. Other Kaiser regions have varying policies, but most standard HMO plans exclude Wegovy for weight loss. Some employer plans that specifically opt-in for weight loss drug coverage may include it—check with your HR department.
Kaiser doctors typically only prescribe medications on the Kaiser formulary. Because they are Kaiser employees, they follow internal protocols. If Wegovy isn't on your plan's formulary, your Kaiser PCP will likely not prescribe it. You can request a referral to bariatric medicine specialists who may have more flexibility, or explore telehealth options outside Kaiser (though you'd pay out of pocket).
Kaiser uses specific terminology. A grievance is for issues like not being able to get a prescription or referral—essentially complaints about care or access. An appeal (or redetermination) is for challenging a specific coverage denial, like when a prescription is denied by the pharmacy. If your doctor won't prescribe Wegovy, file a grievance. If your prescription was denied for coverage, file an appeal.
You or your prescriber can request a formulary exception by calling 1-866-206-2973 (for California), through the kp.org member portal, or in writing. You'll need to demonstrate why the formulary alternatives don't work for you and provide documentation of failed treatments. Approval is not guaranteed—Kaiser's internal formulary decisions are strict.
The California Department of Managed Health Care (DMHC) oversees HMOs like Kaiser. If Kaiser denies your appeal, California members can request an Independent Medical Review—an external review by physicians not employed by Kaiser. IMR decisions are legally binding on Kaiser. About 55% of medical necessity denials are overturned through IMR, and another ~25% are reversed by plans before IMR completes. Contact DMHC at 1-888-466-2219 or dmhc.ca.gov.
Coverage varies by plan. Ozempic contains the same active ingredient as Wegovy (semaglutide) but is FDA-approved for Type 2 diabetes rather than weight loss. Some Kaiser plans cover Ozempic for diabetes management after other medications have failed. If you have Type 2 diabetes, ask your Kaiser endocrinologist about Ozempic—you may have a coverage pathway that doesn't exist for weight loss.
Typically no. The Wegovy savings card (as little as $25) only works with commercial insurance that covers Wegovy. Since most Kaiser plans don't cover Wegovy, the savings card won't apply. If you have Kaiser and want Wegovy, NovoCare Pharmacy offers self-pay pricing: injectable at $199–$349/month, or the new oral pill at $149–$299/month.[4] Retail without discount is ~$1,600/month.
In regions where Wegovy is covered, Kaiser requires extensive step therapy. Kaiser Northwest, for example, requires: (1) documented diet and exercise program, (2) failure of at least 2 weight loss medications (phentermine, Qsymia, Contrave, etc.), AND (3) a minimum 6-month trial of semaglutide (Wegovy or Ozempic) that was ineffective or not tolerated. This is stricter than most other insurers.
Coverage varies by plan and indication. Kaiser may cover Ozempic (semaglutide) for Type 2 Diabetes as it's often on the diabetes formulary—same active ingredient as Wegovy. Mounjaro (tirzepatide) may also be covered for diabetes. However, using these medications "off-label" for weight loss typically isn't covered. If you have Type 2 Diabetes and want a GLP-1, ask your Kaiser endocrinologist about Ozempic or Mounjaro—you may have a coverage pathway that doesn't exist for weight loss alone.
Kaiser Northwest has documented coverage criteria for Wegovy. Coverage is available if you meet strict requirements: BMI ≥30 (or ≥27 with comorbidity), failed 2+ other weight loss medications, AND tried semaglutide for at least 6 months. This is actually more specific documentation than some other Kaiser regions provide. Check the Kaiser Northwest formulary PDF or call 1-800-813-2000 for details.
YOUR PATH FORWARD
What's Next
Quick Decision Guide
Is your BMI ≥ 40?
Do you have Type 2 Diabetes?
Do you have sleep apnea symptoms?
None of the above apply?
Already denied and want to appeal?
All Your Options
Wegovy Coverage: Other Major Insurers
See how other insurers compare on Wegovy coverage:
- UnitedHealthcare — Coverage varies by plan; many require PA
- Blue Cross Blue Shield — Major 2026 coverage restrictions announced
- Cigna — Cigna plans may require step therapy; check your plan’s policy
- Aetna — Most plans cover with prior authorization
- Anthem Blue Cross — Separate policies from other BCBS affiliates
Your GLP-1 coverage,
denied approved
✓ Free Templates✓ Premium Support Available
I was denied coverage for...
Get startedReferences
- Warner Pacific Insurance Services. (2024). "Kaiser Permanente Changes Coverage for Weight Loss Drugs." Effective January 1, 2025, coverage removed from base plans for BMI <40 per CA Title 28 Rule 1300.67.24(e)(3). warnerpacific.com
- SingleCare. (2025). "Does Kaiser cover Wegovy?" singlecare.com
- Kaiser Permanente Northwest. (2024). "Semaglutide (Wegovy) Criteria for Coverage." kaiserpermanente.org (PDF)
- Novo Nordisk. (November 2025). "Novo Nordisk launches introductory self-pay offer for Wegovy® and Ozempic® for $199 per month." Standard pricing $349/month via NovoCare Pharmacy. prnewswire.com
- Kaiser Permanente. (2024). "Redetermination Form (CA)." kaiserpermanente.org (PDF)
- California Department of Managed Health Care. (2024). "Independent Medical Review (IMR) Determinations, Trend." data.chhs.ca.gov
- Glassbox Media / GM Lawyers. (2025). "DMHC Independent Medical Review Data." gmlawyers.com
- Kaiser Permanente. (2025). "Weight-Loss Medicines." kaiserpermanente.org
- Wilding JPH, et al. (2021). "Once-Weekly Semaglutide in Adults with Overweight or Obesity." N Engl J Med. STEP 1 trial. PubMed
- California DMHC. (2025). "File a Complaint." dmhc.ca.gov
- STAT News. (November 6, 2025). "Trump announces deal with Lilly, Novo to expand access to weight loss drugs, cut prices." TrumpRx.gov launched February 5, 2026; TrumpRx lists the manufacturers’ own self-pay prices (not a separate, cheaper price). statnews.com
- GoodRx. (2026). "Wegovy Prices, Coupons & Savings Tips." Average retail price ~$1,615/month for injectable. goodrx.com
- California State Senate. (2025). "Senator Wiener Introduces Legislation to Hold Insurance Companies Accountable." Cites 72% of health plan denials reaching IMR are overturned. sd11.senate.ca.gov
- U.S. Food and Drug Administration. (December 20, 2024). "FDA Approves First Medication for Obstructive Sleep Apnea." Zepbound (tirzepatide) approved for moderate-to-severe OSA in adults with obesity. fda.gov
- BioSpace. (January 5, 2026). "Novo Unveils Oral Wegovy in the US, With Out-of-Pocket Prices at $149 Per Month." Oral pill pricing: $149–$299/month by dose. biospace.com
Last updated October 6, 2026 · Key facts verified October 5, 2026
Disclaimer
The information on this page is for educational and informational purposes only and is not intended as medical advice. Honest Care does not provide medical diagnosis, treatment, or individualized recommendations. Always seek the advice of your physician or other qualified healthcare professional regarding any medical condition or treatment.
While this content has been reviewed for accuracy and balance, new evidence may emerge after publication. Drug availability, indications, and insurance coverage can change over time. Honest Care makes no warranties as to completeness or currentness of the information and is not responsible for decisions made based on this content.